Condition: Follicular Lymphoma · Sponsor: Celgene
The study is designed as a multicenter, randomized, open label Phase 3 study to compare the efficacy and safety of golcadomide in combination with rituximab vs investigator's choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 8559073286 · Clinical.Trials@bms.com
First line of the email MUST contain the NCT# and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0225 | Birmingham, Alabama, United States | Not Yet Recruiting |
| Infirmary Cancer Care | Mobile, Alabama, United States | Recruiting |
| Alaska Oncology and Hematology | Anchorage, Alaska, United States | Recruiting |
| Local Institution - 0215 | Little Rock, Arkansas, United States | Not Yet Recruiting |
| City of Hope Comprehensive Cancer Center | Duarte, California, United States | Recruiting |
| UCSF Helen Diller Medical Center at Parnassus Heights | San Francisco, California, United States | Recruiting |
| Local Institution - 0008 | Jacksonville, Florida, United States | Not Yet Recruiting |
| Local Institution - 0214 | Tampa, Florida, United States | Not Yet Recruiting |
| Local Institution - 0217 | Tampa, Florida, United States | Not Yet Recruiting |
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital | Marietta, Georgia, United States | Recruiting |
| Southeastern Regional Medical Center | Newnan, Georgia, United States | Recruiting |
| Local Institution - 0240 | Arlington Heights, Illinois, United States | Not Yet Recruiting |
+ 148 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06911502